Mots-clés
Documents disponibles dans cette catégorie (255)
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
Hervier B, Uzunhan Y
Frontiers in medicine, 2020, 6, p 326
A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis
Peng QL, Zhang YM, Liang L, et al.
Clinical and experimental immunology, 2019
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Signorelli M, Ayoglu B, Johansson C, et al.
Journal of cachexia, sarcopenia and muscle, 2019
Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy
Alves CRR, Zhang R, Johnstone AJ, et al.
Neurology, 2019
Dermatomyosites - Nouveaux anticorps, nouvelle classification : Dermatomyositis: new antibodies, new classification
Bolko L, Gitiaux C, Allenbach Y
Les Cahiers de Myologie, 2019, 35, HS2, p 18
Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging
Monforte M, Laschena F, Ottaviani P, et al.
Journal of cachexia, sarcopenia and muscle, 2019
Zoom sur... L'amyotrophie spinale proximale liée au gène SMN1
Myoinfo (AFM-Téléthon), Duguet C, Dupitier E, et al.
Zoom sur ..., Savoir & Comprendre, 2019, 130
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy
Gigli M, Merlo M, Graw SL, et al.
Journal of the American College of Cardiology, 2019, 74, 11, p 1480
Modelling disease activity in juvenile dermatomyositis: A Bayesian approach
van Dijkhuizen EP, Deakin CT, Wedderburn LR, et al.
Statistical methods in medical research, 2019, 28, 1, p 35
Physicians' attitudes when faced with life-threatening events in children with severe neurological disabilities
Wosinski B, Newman CJ
Developmental neurorehabilitation, 2018
Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1
Wahbi K, Porcher R, Laforêt P, et al.
JAMA Neurology, 2018, 75, 5, p 573
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
McDonald CM, Henricson EK, Abresch RT, et al.
Lancet (London, England), 2018, 391, 10119, p 451
Longitudinal timed function tests in Duchenne muscular dystrophy: Imaging DMD cohort natural history
Arora H, Willcocks RJ, Lott DJ, et al.
Muscle & Nerve, 2018, 58, 5, p 631
Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
Calucho M, Bernal S, Alias L, et al.
Neuromuscular disorders : NMD, 2018, 28, 3, p 208
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Parini R, De Lorenzo P, Dardis A, et al.
Orphanet journal of rare diseases, 2018, 13, 1
Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis
Fayssoil A, Ben Yaou R, Ogna A, et al.
PLoS ONE, 2018, 13, 1
